Eating satiating, protein-rich foods is one of the key aspects of modern diet, although a bitter off-taste often limits the application of some proteins and protein hydrolysates, especially in processed foods. Previous studies of our group demonstrated that bitter-tasting food constituents, such as caffeine, stimulate mechanisms of gastric acid secretion as a signal of gastric satiation and a key process of gastric protein digestion via activation of bitter taste receptors (TAS2Rs). Here, we tried to elucidate whether dietary non-bitter-tasting casein is intra-gastrically degraded into bitter peptides that stimulate mechanisms of gastric acid secretion in physiologically achievable concentrations. An in vitro model of gastric digestion was verified by casein-fed pigs, and the peptides resulting from gastric digestion were identified by liquid chromatography-time-of-flight-mass spectrometry. The bitterness of five selected casein-derived peptides was validated by sensory analyses and by an in vitro screening approach based on human gastric parietal cells (HGT-1). For three of these peptides (YFYPEL, VAPFPEVF, and YQEPVLGPVRGPFPIIV), an upregulation of gene expression of TAS2R16 and TAS2R38 was observed. The functional involvement of these TAS2Rs was verified by siRNA knock-down (kd) experiments in HGT-1 cells. This resulted in a reduction of the mean proton secretion promoted by the peptides by up to 86.3 ± 9.9% for TAS2R16kd (p < 0.0001) cells and by up to 62.8 ± 7.0% for TAS2R38kd (p < 0.0001) cells compared with mock-transfected cells.
About half of the world's population is infected with the bacterium Helicobacter pylori. For colonization, the bacterium neutralizes the low gastric pH and recruits immune cells to the stomach. The immune cells secrete cytokines, i.e., the pro-inflammatory IL-17A, which directly or indirectly damage surface epithelial cells. Since (I) dietary proteins are known to be digested into bitter tasting peptides in the gastric lumen, and (II) bitter tasting compounds have been demonstrated to reduce the release of pro-inflammatory cytokines through functional involvement of bitter taste receptors (TAS2Rs), we hypothesized that the sweet-tasting plant protein thaumatin would be cleaved into anti-inflammatory bitter peptides during gastric digestion. Using immortalized human parietal cells (HGT-1 cells), we demonstrated a bitter taste receptor TAS2R16-dependent reduction of a H. pylori-evoked IL-17A release by up to 89.7 ± 21.9% (p ≤ 0.01). Functional involvement of TAS2R16 was demonstrated by the study of specific antagonists and siRNA knock-down experiments.
20 February 2024 in Journal of Agricultural and Food Chemistry
Gastric parietal cells secrete chloride ions and protons to form hydrochloric acid. Besides endogenous stimulants, e.g., acetylcholine, bitter-tasting food constituents, e.g., caffeine, induce proton secretion via interaction with bitter taste receptors (TAS2Rs), leading to increased cytosolic Ca2+ and cAMP concentrations. We hypothesized TAS2R activation by bitter tastants to result in proton secretion via cellular Na+ influx mediated by transient receptor potential channels (TRP) M4 and M5 in immortalized human parietal HGT-1 cells. Using the food-derived TAS2R agonists caffeine and l-arginine, we demonstrate both bitter compounds to induce a TRPM4/M5-mediated Na+ influx, with EC50 values of 0.65 and 10.38 mM, respectively, that stimulates cellular proton secretion. Functional involvement of TAS2Rs in the caffeine-evoked effect was demonstrated by means of the TAS2R antagonist homoeriodictyol, and stably CRISPR-Cas9-edited TAS2R43ko cells. Building on previous results, these data further support the suitability of HGT-1 cells as a surrogate cell model for taste cells. In addition, TRPM4/M5 mediated a Na+ influx after stimulating HGT-1 cells with the acetylcholine analogue carbachol, indicating an interaction of the digestion-associated cholinergic pathway with a taste-signaling pathway in parietal cells.
The casein-derived bitter peptide VAPFPEVF has been shown to stimulate proton secretion in human parietal cells (HGT-1) via bitter taste receptor TAS2R16, confirmed by siRNA knockdown. Since literature evidence is inconclusive, we hypothized that VAPFPEVF binds to TAS2R16, and investigated its effects on G protein-coupled signaling pathways. Exposure of HGT-1 cells to VAPFPEVF altered cAMP signaling without inducing a calcium response. An atomic force microscopy (AFM)-based approach was employed to demonstrate peptide binding to TAS2R16 in cellular and cell-free environments using TAS2R16-reconstituted proteoliposomes. Increased binding events were observed, reduced by the addition of salicin and TAS2R16 antagonist probenecid. AlphaFold multimer and molecular dynamics simulations suggest VAPFPEVF binds the orthosteric site of TAS2R16. These findings reveal (i) VAPFPEVF interacts with TAS2R16 to modulate cAMP levels without triggering calcium mobilization and (ii) the AFM approach as a valuable tool for studying peptide binding to TAS2R16 and possibly other G-protein coupled transmembrane receptors.
The lysosomal Ca2+ channel TRPML1 was found to be responsible for gastric acid secretion in murine gastric parietal cells by inducing the trafficking of H+/K+-ATPase containing tubulovesicles to the apical membrane. Therefore, we hypothesized a similar role of TRPML1 in regulating proton secretion in the immortalized human parietal cell line HGT-1. The primary focus was to investigate the involvement of TRPML1 in proton secretion using the known synthetic agonists ML-SA1 and ML-SA5 and the antagonist ML-SI3 and, furthermore, to identify food-derived compounds that target the channel. Proton secretion stimulated by ML-SA1 was reduced by 122.2 ± 22.7% by the antagonist ML-SI3. The steroid hormone 17β-estradiol, present in animal-derived foods, diminished the proton secretory effect of ML-SA1 by 63.4 ± 14.5%. We also demonstrated a reduction in the proton secretory effects of ML-SA1 and ML-SA5 on TRPML1 knock-down cells. The food-derived compounds sulforaphane and trehalose promoted proton secretion in HGT-1 cells but may act independently of TRPML1. Also, histamine- and caffeine-induced proton secretion were affected by neither the TRPML1 antagonist ML-SI3 nor the TRPML1 knock-down. In summary, the results obtained suggest that the activation of TRPML1 promotes proton secretion in HGT-1 cells, but the channel may not participate in canonical signaling pathways.
20 March 2026 in Molecular Nutrition & Food Research
The effects of herbal remedies aiding digestion are well known, but the underlying mechanisms remain poorly understood. Notably, many of these preparations are bitter, and bitter‐tasting phenolic food constituents have been shown to induce digestive processes by activating extra‐oral bitter taste receptors (TAS2Rs). This study examined the effects of a commercially available herbal mixture preparation used to aid digestive discomfort and nine solvent extracts thereof on proton secretion of immortalized human parietal cells (HGT‐1). The bitter taste of the preparation was sensorially evaluated, and its impact on the gene expression of the polyphenol‐related receptors TAS2R4 , TAS2R5 , and TAS2R39 was analyzed. Functional TAS2R involvement was validated using CRISPR‐Cas9 knock‐out and siRNA knock‐down approaches. Total polyphenol content was quantified using Folin‐Ciocalteu reagent. The bitter‐tasting herbal mixture preparation and several of its solvent extracts stimulated proton secretion by HGT‐1 cells concentration‐dependently. Four extracts exhibited high total polyphenol content and induced strong secretory responses, whereas five extracts showed lower content and weaker effects ( p < 0.01). Reduced responses were observed in TAS2R4ko, TAS2R5kd, and TAS2R39ko cells. In conclusion, bitter‐tasting plant extracts can stimulate TAS2R‐mediated digestive processes depending on their total polyphenol content, thereby supporting their use as promising remedies for alleviating digestive discomfort.